Alcohol and wine in relation to cancer and other diseases

European Journal of Cancer Prevention

Volumn 21, Issue 1, 2012, Pages 103-108

  Giacosa, Attilio ^a,b   Adam Blondon, Anne F ^p   Baer Sinnott, Sara ^q   Barale, Roberto ^c   Bavaresco, Luigi ^d   Di Gaspero, Gabriele ^e,f   Dugo, Laura ^g   Curtis Ellison, Robert ^r   Gerbi, Vincenzo ^j   Gifford, Dun ^q   Janssens, Jaak ^s   La Vecchia, Carlo ^k,l   Negri, Eva ^k   Pezzotti, Mario ^m   Santi, Leonardo ^h   Santi, Luca ⁱ   Rondanelli, Mariangela ^n,o  

^a UNIVERSITY OF GENOA   (Italy)

^b Policlinico di Monza   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d CRA Research Centre for Viticulture   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

^f Istituto di Genomica Applicata   (Italy)

^g UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^h National Commitee for Biosecurity Biotechnology and Life Sciences   (Italy)

ⁱ UNIVERSITY OF ROME TOR VERGATA   (Italy)

^j UNIVERSITY OF TURIN   (Italy)

^k MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^l UNIVERSITY OF MILAN   (Italy)

^m UNIVERSITY OF VERONA   (Italy)

ⁿ UNIVERSITY OF PAVIA   (Italy)

^o ASP (Azienda di Servizi alla Persona) of Pavia   (Italy)

^p CEMAGREF   (France)

^q Oldways Preservation Trust   (United States)

^r BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s European Cancer Prevention Organization   (Belgium)

more..

Author keywords

Alcohol; Cancer; Genomics; Polyphenols; Resveratrol; Wine

Indexed keywords

ALCOHOL; ANTHOCYANIN; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; GRAPE SEED EXTRACT; MONOMERIC FLAVAN 3 OL; NUTRACEUTICAL; PHENOL; POLYPHENOL; PROTEIN BCL 2; PROTEIN KINASE B; RESVERATROL; STILBENE; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG MECHANISM; GENETIC VARIABILITY; HEART PROTECTION; HUMAN; LIVER DISEASE; MORTALITY; NEOPLASM; NEUROPROTECTION; NUTRIGENOMICS; PRIORITY JOURNAL; REVIEW; SYNTHESIS; UPREGULATION; WINE;

ALCOHOL DRINKING; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS; WINE;

EID: 82555169614     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834761d3     Document Type: Review

References (60)

1. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004). Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783-2840. (Pubitemid 39409568)
2. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. (2007). Carcinogenicity of alcoholic beverages. Lancet Oncol 8:292-293.
3. Baur JA, Sinclair DA (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506. (Pubitemid 44136961)
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342. (Pubitemid 44764104)
5. Bavaresco L, Fregoni C, Van Zeller De Macedo Basto Gancalves MI, Vezzulli S (2009). Physiology and molecular biology of grapevine stilbenes: an update. In: Roubelakis-Angelakis KA, editor. Grapevine molecular physiology and biotechnology. 2nd ed. Heidelberg: Springer; pp. 341-364.
6. Bishayee A (2009). Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res 2:409-418.
7. Bisson LF, Waterhouse AL, Ebeler SE, Walker MA, Lapsley JT (2002). The present and future of the international wine industry. Nature 418:696-699.
8. Boffetta P, Tubiana M, Hill C, Boniol M, Aurengo A, Masse R, et al. (2009). The causes of cancer in France. Ann Oncol 20:550-555.
9. Bogs J, Jaffé FW, Takos AM, Walker AR, Robinson SP (2007). The grapevine transcription factor VvMYBPA1 regulates proanthocyanidin synthesis during fruit development. Plant Physiol 143:1347-1361. (Pubitemid 46941551)
10. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C (2007). Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46:827-839. (Pubitemid 46529045)
11. Calabrese EJ, Mattson MP, Calabrese V (2010). Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum Exp Toxicol 29:980-1015.
12. Castellarin SD, Di Gaspero G, Marconi R, Nonis A, Peterlunger E, Paillard S, et al. (2006). Colour variation in red grapevines (Vitis vinifera L): genomic organisation, expression of flavonoid 3′-hydroxylase, flavonoid 3′,5′-hydroxylase genes and related metabolite profiling of red cyanidin-/blue delphinidin-based anthocyanins in berry skin. BMC Genomics 7:12.
13. Castellarin SD, Matthews MA, Di Gaspero G, Gambetta GA (2007a). Water deficit accelerates ripening and induces changes in gene expression regulating flavonoid biosynthesis in grape berries. Planta 227:101-112. (Pubitemid 350222828)
14. Castellarin SD, Pfeiffer A, Sivilotti P, Degan M, Peterlunger E, Di Gaspero G (2007b). Transcriptional regulation of anthocyanin biosynthesis in ripening fruits of grapevine under seasonal water deficit. Plant Cell Environ 30:1381-1399. (Pubitemid 47493863)
15. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, et al. (2009). Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 33:206-219.
16. Conde C, Silva P, Fontes N, Dias ACP, Tavares RM, Sousa MJ, et al. (2007). Biochemical changes throughout grape berry development and fruit and wine quality. Food 1:1-22.
17. Corder R, Mullen W, Khan NQ, Marks SC, Wood EG, Carrier MJ, et al. (2006). Oenology: red wine procyanidins and vascular health. Nature 444:566. (Pubitemid 44864428)
18. Corrao G, Bagnardi V, Zambon A, La Vecchia C (2004). A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38: 613-619. (Pubitemid 38452887)
19. Cramer GR, Ergül A, Grimplet J, Tillett RL, Tattersall EAR, Bohlman MC, et al. (2007). Water and salinity stress in grapevines: early and late changes in transcript and metabolite profiles. Funct Integr Genom 7:111-134. (Pubitemid 46336167)
20. Cutanda-Perez MC, Ageorges A, Gomez C, Vialet S, Terrier N, Romieu C, et al. (2009). Ectopic expression of VlmybA1 in grapevine activates a narrow set of genes involved in anthocyanin synthesis and transport. Plant Mol Biol 69:633-648.
21. Das DK, Maulik N (2006). Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv 6:36-47. (Pubitemid 43327521)
22. Das S, Das DK (2007). Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets 6:168-173. (Pubitemid 47455785)
23. De la Lastra CA, Villegas I (2007). Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 35:1156-1160. (Pubitemid 350206449)
24. Deluc LG, Grimplet J, Wheatley MD, Tillett RL, Quilici DR, Osborne C, et al. (2007). Transcriptomic and metabolite analyses of Cabernet Sauvignon grape berry development. BMC Genomics 8:429.
25. Doll R, Forman D, La Vecchia C,Woutersen R (1999). Alcoholic beverages and cancers of the digestive tract and larynx. In: Macdonald I, editor. Health issues related to alcohol consumption. 2nd ed. Oxford: Blackwell. pp. 351-393.
26. Doll R, Peto R, Boreham J, Sutherland I (2005). Mortality in relation to alcohol consumption: a prospective study among male British doctors. Int J Epidemiol 34:199-204. (Pubitemid 40347395)
27. Duchene E, Huard F, Dumas V, Schneider C, Merdinoglu D (2010). The challenge of adapting grapevine varieties to climate change. Climate Res 41:193-204.
28. D'Avanzo B, La Vecchia C, Braga C, Franceschi S, Negri E, Parpinel M (1997). Nutrient intake according to education, smoking and alcohol in Italian women. Nutr Cancer 28:46-51. (Pubitemid 27287628)
29. Ellison RC (2002). Balancing the risks and benefits of moderate drinking. Ann N Y Acad Sci 957:1-6. (Pubitemid 34721648)
30. Farchi G, Fidanza F, Giampaoli S, Mariotti S, Menotti A (2000). Alcohol and survival in the Italian rural cohorts of the Seven Countries Study. Int J Epidemiol 29:667-671. (Pubitemid 30612233)
31. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. (2011). Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol [Epub ahead of print].
32. Ferraroni M, Decarli A, Franceschi S, La Vecchia C (1998). Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study. Eur J Cancer 34:1403-1409. (Pubitemid 28370933)
33. Fournier-Level A, Le Cunff L, Gomez C, Doligez A, Ageorges A, Roux C, et al. (2009). Quantitative genetic bases of anthocyanin variation in grape (Vitis vinifera L ssp. sativa) berry: a quantitative trait locus to quantitative trait nucleotide integrated study. Genetics 183:1127-1139.
34. Grønbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, et al. (2000). Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 133:411-419.
35. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, Heath CWJr, et al. (2002). Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87:1234-1245.
36. Harikumar KB, Aggarwal BB (2008). Resveratrol: a multitargeted agent for ageassociated chronic diseases. Cell Cycle 7:1020-1035.
37. Islami F, Tramacere I, Rota M, Bagnardi V, Fedirko V, Scotti L, et al. (2010). Alcohol drinking and laryngeal cancer: overall and dose-risk relation. A systematic review and meta-analysis. Oral Oncol 46:802-810.
38. Jaillon O, Aury J-M, Noel B, Policriti A, Clepet C, Casagrande A, et al. (2007). The grapevine genome sequence suggests ancestral hexaploidization in major angiosperm phyla. Nature 449:463-468.
39. Jones GV, White MA, Cooper OR, Storchmann K (2005). Climate change and global wine quality. Climate Change 73:319-343. (Pubitemid 41627623)
40. La Vecchia C (1995). Alcohol in the Mediterranean diet: assessing risks and benefits. Eur J Cancer Prev 4:3-5.
41. La Vecchia C (2007). Alcohol and liver cancer. Eur J Cancer Prev 16:495-497. (Pubitemid 350307497)
42. Maisonneuve P, Lowenfels AB (2010). Epidemiology of pancreatic cancer: an update. Dig Dis 28:645-656.
43. Meeran SM, Katiyar SK (2008). Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 13:2191-2202. (Pubitemid 351589245)
44. Mukherjee S, Dudley JI, Das DK (2010). Dose-dependency of resveratrol in providing health benefits. Dose Response 8:478-500.
45. Nandakumar V, Singh T, Katiyar SK (2008). Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269:378-387.
46. Opie LH, Lecour S (2007). The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28:1683-1693. (Pubitemid 47227092)
47. Pilati S, Perazzolli M, Malossini A, Cestaro A, Demattè L, Fontana P, et al. (2007). Genome-wide transcriptional analysis of grapevine berry ripening reveals a set of genes similarly modulated during three seasons and the occurrence of an oxidative burst at Véraison. BMC Genomics 8:428.
48. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, et al. (2008). Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15:1545-1551. (Pubitemid 351997786)
49. Rehm J, Sempos CT, Trevisan M (2003). Alcohol and cardiovascular disease- more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease: a review. J Cardiovasc Risk 10:15-20.
50. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373:2223-2233.
51. Saiko P, Pemberger M, Horvath Z, Savinc I, Grusch M, Handler N, et al. (2008). Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity. Oncol Rep 19:1621-1626.
52. Samuelian SK, Camps C, Kappel C, Simova EP, Delrot S, Colova V (2009). Differential screening of overexpressed genes involved in flavonoid biosynthesis in North American native grapes: 'Noble' muscadinia var. and 'Cynthiana' aestivalis var. Plant Sci 177:211-221.
53. Terrier N, Glissant D, Grimplet J, Barrieu F, Abbal P, Couture C, et al. (2005). Isogene specific oligo arrays reveal multifaceted changes in gene expression during grape berry (Vitis vinifera L) development. Planta 222:832-847. (Pubitemid 41660829)
54. Terrier N, Torregrosa L, Ageorges A, Vialet S, Verriè s C, Cheynier V, et al. (2009). Ectopic expression of VvMybPA2 promotes proanthocyanidin biosynthesis in grapevine and suggests additional targets in the pathway. Plant Physiol 149:1028-1041.
55. Tramacere I, Negri E, Bagnardi V, Garavello W, Rota M, Scotti L, et al. (2010). A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: overall results and dose-risk relation. Oral Oncol 46:497-503.
56. Vidavalur R, Otani H, Singal PK, Maulik N (2006). Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11:217-225. (Pubitemid 44540866)
57. Vincent D, Ergül A, Bohlman MC, Tattersall EAR, Tillett RL, Wheatley MD, et al. (2007). Proteomic analysis reveals differences between Vitis vinifera L cv. Chardonnay and cv. Cabernet Sauvignon and their responses to water deficit and salinity. J Exp Bot 58:1873-1892. (Pubitemid 47356001)
58. Wooding S (2006). Phenylthiocarbamide: a 75-year adventure in genetics and natural selection. Genetics 172:2015-2023.
59. Zamboni A, Di Carli M, Guzzo F, Stocchero M, Zenoni S, Ferrarini A, et al. (2010). Identification of putative stage-specific grapevine berry biomarkers and omics data integration into networks. Plant Physiol 154:1439-1459.
60. Zenoni S, Ferrarini A, Giacomelli E, Xumerle L, Fasoli M, Malerba G, et al. (2010). Characterization of transcriptional complexity during berry development in Vitis vinifera using RNA-Seq. Plant Physiol 152:1787-1795.